• Medientyp: E-Artikel
  • Titel: Serum miR-34a-5p and miR-199a-3p as new biomarkers of neonatal sepsis
  • Beteiligte: Abdelaleem, Omayma O.; Mohammed, Shereen Rashad; El Sayed, Hassan S.; Hussein, Sherin Khamis; Ali, Doaa Y.; Abdelwahed, Mostafa Y.; Gaber, Sylvana N.; Hemeda, Nada F.; El-Hmid, Rehab G. Abd
  • Erschienen: Public Library of Science (PLoS), 2022
  • Erschienen in: PLOS ONE
  • Sprache: Englisch
  • DOI: 10.1371/journal.pone.0262339
  • ISSN: 1932-6203
  • Entstehung:
  • Anmerkungen:
  • Beschreibung: <jats:sec id="sec001"> <jats:title>Background</jats:title> <jats:p>Neonatal sepsis is a serious condition. Recent clinical studies have indicated that microRNAs (miRNAs) are key players in the pathogenesis of sepsis, which could be used as biomarkers for this condition.</jats:p> </jats:sec> <jats:sec id="sec002"> <jats:title>Patients and methods</jats:title> <jats:p>A total of 90 neonates with sepsis and 90 healthy neonates were enrolled in this study. qRT-PCR was performed to measure the expression levels of serum miR-34a-5p and miR-199a-3p.</jats:p> </jats:sec> <jats:sec id="sec003"> <jats:title>Results</jats:title> <jats:p>miR-34a-5p and miR-199a-3p serum levels were significantly reduced in neonates with sepsis compared with those in healthy neonates (P = 0.006 and P = 0.001, respectively). Significant correlations of miR-34a-5p and miR-199a-3p with each of TLC, RDW, RBS, and C-reactive protein (CRP) as well as SNAPII were observed, indicating their associations with the severity of neonatal sepsis.</jats:p> </jats:sec> <jats:sec id="sec004"> <jats:title>Conclusion</jats:title> <jats:p>miR-34a-5p and miR-199a-3p may be useful as novel biomarkers in neonatal sepsis and may provide a new direction for its treatment.</jats:p> </jats:sec>
  • Zugangsstatus: Freier Zugang